1. Home
  2. CNDT vs CGEM Comparison

CNDT vs CGEM Comparison

Compare CNDT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • CGEM
  • Stock Information
  • Founded
  • CNDT 2016
  • CGEM 2016
  • Country
  • CNDT United States
  • CGEM United States
  • Employees
  • CNDT N/A
  • CGEM N/A
  • Industry
  • CNDT Business Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNDT Consumer Discretionary
  • CGEM Health Care
  • Exchange
  • CNDT Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CNDT 497.6M
  • CGEM 506.1M
  • IPO Year
  • CNDT N/A
  • CGEM 2021
  • Fundamental
  • Price
  • CNDT $2.70
  • CGEM $7.30
  • Analyst Decision
  • CNDT
  • CGEM Strong Buy
  • Analyst Count
  • CNDT 0
  • CGEM 8
  • Target Price
  • CNDT N/A
  • CGEM $32.86
  • AVG Volume (30 Days)
  • CNDT 1.1M
  • CGEM 400.4K
  • Earning Date
  • CNDT 04-30-2025
  • CGEM 05-14-2025
  • Dividend Yield
  • CNDT N/A
  • CGEM N/A
  • EPS Growth
  • CNDT N/A
  • CGEM N/A
  • EPS
  • CNDT 2.23
  • CGEM N/A
  • Revenue
  • CNDT $3,356,000,000.00
  • CGEM N/A
  • Revenue This Year
  • CNDT N/A
  • CGEM N/A
  • Revenue Next Year
  • CNDT $2.19
  • CGEM $278.37
  • P/E Ratio
  • CNDT $1.22
  • CGEM N/A
  • Revenue Growth
  • CNDT N/A
  • CGEM N/A
  • 52 Week Low
  • CNDT $2.70
  • CGEM $7.30
  • 52 Week High
  • CNDT $4.90
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 22.25
  • CGEM 30.15
  • Support Level
  • CNDT $2.88
  • CGEM $7.30
  • Resistance Level
  • CNDT $3.10
  • CGEM $9.16
  • Average True Range (ATR)
  • CNDT 0.11
  • CGEM 0.44
  • MACD
  • CNDT -0.01
  • CGEM -0.07
  • Stochastic Oscillator
  • CNDT 2.88
  • CGEM 4.57

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: